Marinus Pharmaceuticals Gets FDA Orphan Drug Status For Ganaxolone IV
April 15, 2016 at 10:04 AM EDT
Marinus Pharmaceuticals Inc (NASDAQ: MRNS) revealed the FDA has granted Orphan Drug Designation to its intravenous formation of its ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.